-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

902.O4.6 902. Health Services and Outcomes Research – Malignant Diseases: Clinical Trials and Health Outcomes

Health Services and Outcomes Research – Malignant Diseases Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 10:30 AM-12:00 PM
Chapin Theater (W320), Level 3 (Orange County Convention Center)
Moderators:
Heather Jim, PhD, H. Lee Moffitt Cancer Center and Research Institute and William A. Wood, MD, MPH, University of North Carolina

Disclosures:
Wood: Inform Genomics: Consultancy ; Best Doctors: Consultancy .
10:30 AM

Ashley M. Perry, BS1*, Tao Zou, MD, PhD1*, Andrew M. Brunner, MD1,2, Donna S Neuberg, ScD3 and Amir T. Fathi, MD1

1Massachusetts General Hospital, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA

10:45 AM

Kimberley Blackwell1*, Ruslan Paltuev2*, Roman Donskih3*, Olga Burdaeva4*, Elena Bit-Sava5*, Tanveer Maksud6*, Michael Jones7*, Allen Nixon8*, Maria J Vidal9*, Roumen Nakov10*, Pritba Singh10*, Gregor Schaffer10*, Pere Gascon11 and Nadia Harbeck12*

1Duke University, Durham, NC
2Railway Clinical Hospital of OJSC "RZhD", St Petersburg, Russia
3Scientific Research Oncology Institute n.a. N.N. Petrov, St Petersburg, Russia
4Arkhangelsk Clinical Oncology Dispensary Oncology Research Center, Arkhangelsk, Russia
5Saint-Petersburg State Medical University n.a.acad. I.P. Pavlov, St Petersburg, Russia
6Bharat Cancer Hospital & Research Institute, Surat, India
7Jones Clinic, Germantown, TN
8Fowler Family Center for Cancer Care, Jonesboro, AR
9Hospital General Vall d’Hebron, Barcelona, Spain
10Hexal AG/Sandoz Biopharmaceuticals, Holzkirchen/Oberhaching, Germany
11Hospital Clinic de Barcelona, Barcelona, Spain
12Breast Center, University of Munich, Munich, Germany

11:00 AM

Luciano J Costa, MD, PhD1 and Elizabeth E. Brown, PhD, MPH2

1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2University of Alabama At Birmingham, Birmingham, AL

11:15 AM

Luciano J Costa, MD, PhD1, Parameswaran Hari, MD, MRCP, MS2 and Shaji Kumar, MD3

1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2Medical College of Wisconsin, Milwaukee, WI
3Division of Hematology, Mayo Clinic, Rochester, MN

11:30 AM

Abby Statler, MPH, MA1*, Tomas Radivoyevitch, PhD2*, Caitlin Siebenaller, PharmD, BCOP3*, Aaron T. Gerds, MD, MS4, Matt Kalaycio, MD5, Eric Kodish, MD6*, Sudipto Mukherjee, MD, PhD4, Connie Cheng, PharmD, BCOP3* and Mikkael A. Sekeres, MD, MS4

1Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
2Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
3Leukemia Program, Department of Pharmacy, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Leukemia Program, Cleveland Clinic, Cleveland, OH
5Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
6Center for Ethics, Humanities and Spiritual Care, Cleveland Clinic, Cleveland, OH

11:45 AM

Roslyn Ristuccia, BSc MMedSc1*, Xavier C Badoux, MBBS1, Melinda Gibson, BAppS MHSc1*, Admir Huseincehajic, BSc2*, Judith Trotman, MBChB3 and Haematology Clinical Research Network4*

1Department of Haematology, St George Hospital, Kogarah, Australia
2Department of Haematology, Concord Repatriation General Hospital, Concord, Australia
3Department of Hematology, Concord Repatriation General Hospital, Concord, NSW, Australia
4Haematology Clinical Research Network NSW and ACT, Sydney, Australia

*signifies non-member of ASH